PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 19, 20260 citationsOpen Access

Medical artificial intelligence research is misaligned with global disease burden: a bibliometric analysis of 197,844 publications

View Full Paper
HFHayden Farquhar

Key Points

  • This research aims to quantify the alignment of medical AI publications with global disease burden and identify biases in disease selection.
  • Mapped 197,844 medical AI publications from OpenAlex (2015–2025).
  • Compared publications against 115 Global Burden of Disease Level 3 causes, covering 94.1% of global DALYs.
  • Calculated a Research Attention Index for each disease to measure publication share relative to DALY share.
  • Analyzed data using multivariable regression and simulations for dataset creation strategies.
  • AI research shows moderate alignment with global disease burden (Spearman r_s = 0.477).
  • Top 10 diseases account for 54.4% of all AI publications, showing extreme concentration (Gini 0.718).
  • Over-studied diseases include skin melanoma and brain cancer, while road injuries and anxiety disorders are under-studied.
  • AI research aligns better with burdens in high-income countries (r_s = 0.619) compared to low-income countries (0.239).
  • Strategic dataset creation could help balance research focus towards under-studied, high-burden diseases.

Abstract

Background: Health research funding and output are misaligned with global disease burden, favouring diseases of affluent populations. Medical AI is the fastest-growing segment of health research, but whether it replicates or worsens this misalignment has not been quantified. AI research depends on labelled benchmark datasets that exist for some diseases but not others, creating a potential systematic bias in disease selection. Methods and Findings: We mapped 197,844 medical AI publications (2015–2025) from OpenAlex to 115 Global Burden of Disease (GBD) 2023 Level 3 causes covering 94.1% of global disability-adjusted life years (DALYs). A Research Attention Index (RAI) quantified each disease's publication share relative to its DALY share. AI research was moderately aligned with burden (Spearman *r*~s~ = 0.477; 95% CI 0.318–0.615), with extreme concentration (Gini 0.718): the top 10 diseases received 54.4% of publications. Skin melanoma (RAI 53.0), brain cancer (14.2), and breast cancer (11.4) were over-studied; road injuries (RAI 0.025; 74.7 million DALYs, 57 publications), diarrhoeal diseases (0.034), and anxiety disorders (0.036) were under-studied. AI was far better aligned with high-income-country burden (*r*~s~ = 0.619) than low-income-country burden (0.239). Multivariable regression (*n* = 38 diseases; R² = 0.71) identified dataset availability, research community size, and high-income-country burden share as predictors; burden itself was not significant. Simulation showed that strategic dataset creation for under-studied diseases could make AI a net corrective force. Limitations include title-based disease mapping (recall 75.8%), the small regression sample, and a linear mixing assumption in the corrective model. Conclusions: Medical AI research amplifies the research–burden mismatch — driven not by disease burden but by benchmark dataset availability. Strategic investment in datasets for high-burden, under-studied diseases could transform AI into a corrective force for global health equity.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Hayden Farquhar (2026) studied this question.

synapsesocial.com/papers/69e47220010ef96374d8e554https://doi.org/10.5281/zenodo.19624378
Ask AI
Helpful
Bookmark
Share
View Full Paper